SCHEMBL16280638

SCHEMBL16280638

Cc1ccccc1C(=O)N1CCCC(C(=O)Nc2cccc(C(C)(C)C)c2)[C@@H]1c1cccc(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.53
▸ USP2 O75604 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.43
▸ RIPK1 Q13546 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ UBE2M P61081 3/20 0.41
▸ DCUN1D1 Q96GG9 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TP53 P04637 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12160772 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL2586816 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL29726757 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL18801764 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL29726771 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL2591188 1.00 HSD17B10 (0.53) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL24522176 0.92 HSD17B10 (0.45) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL12176030 0.92 HSD17B10 (0.45) HSD17B10USP2MEN1KMT2ANPSR1
SCHEMBL18609695 0.92 HSD17B10 (0.46) HSD17B10NPSR1RXFP1MAPTUBE2M
SCHEMBL14959019 0.92 HSD17B10 (0.46) HSD17B10NPSR1RXFP1MAPTUBE2M

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102258-A1 C5AR ANTAGONISTS CHEMOCENTRYX, INC. 2023-03-30 — — US disclosed
US-8906938-B2 C5aR antagonists CHEMOCENTRYX, INC. (US) 2014-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230102258-A1 C5AR ANTAGONISTS C5AR1, C5AR2, C3AR1 HSD17B10 4597/4885USP2 3279/4885MEN1 2647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback